Literature DB >> 19810006

Determination of dopamine, serotonin, and their metabolites in pediatric cerebrospinal fluid by isocratic high performance liquid chromatography coupled with electrochemical detection.

K Elaine Hubbard1, Amy Wells, Thandranese S Owens, Michael Tagen, Charles H Fraga, Clinton F Stewart.   

Abstract

A method to rapidly measure dopamine (DA), dihydroxyindolphenylacetic acid, homovanillic acid, serotonin (5-HT) and 5-hydroxyindoleacetic acid concentrations in cerebrospinal fluid (CSF) has not yet been reported. A rapid, sensitive, and specific HPLC method was therefore developed using electrochemical detection. CSF was mixed with an antioxidant solution prior to freezing to prevent neurotransmitter degradation. Separation of the five analytes was obtained on an ESA MD-150 x 3.2 mm column with a flow rate of 0.37 mL/min and an acetonitrile-aqueous (5 : 95, v/v) mobile phase with 75 mM monobasic sodium phosphate buffer, 0.5 mM EDTA, 0.81 mM sodium octylsulfonate and 5% tetrahydrofuran. The optimal electrical potential settings were: guard cell +325 mV, E1 -100 mV and E2 +300 mV. Within-day and between-day precisions were <10% for all analytes and accuracies ranged from 91.0 to 106.7%. DA, 5-HT, and their metabolites were stable in CSF with antioxidant solution at 4 degrees C for 8 h in the autoinjector. This method was used to measure neurotransmitters in CSF obtained from children enrolled on an institutional medulloblastoma treatment protocol. Copyright 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19810006     DOI: 10.1002/bmc.1338

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  19 in total

1.  Electrophoretic separation of neurotransmitters on a polystyrene nano-sphere∕polystyrene sulphonate coated poly(dimethylsiloxane) microchannel.

Authors:  Jinjin Zhao; Qianli Zhang; Huijuan Yang; Yifeng Tu
Journal:  Biomicrofluidics       Date:  2011-07-25       Impact factor: 2.800

Review 2.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

3.  Endogenous opioid activity in the anterior cingulate cortex is required for relief of pain.

Authors:  Edita Navratilova; Jennifer Yanhua Xie; Diana Meske; Chaoling Qu; Kozo Morimura; Alec Okun; Naohisa Arakawa; Michael Ossipov; Howard L Fields; Frank Porreca
Journal:  J Neurosci       Date:  2015-05-06       Impact factor: 6.167

4.  Opioid and noradrenergic contributions of tapentadol in experimental neuropathic pain.

Authors:  Diana S Meske; Jennifer Y Xie; Janice Oyarzo; Hamid Badghisi; Michael H Ossipov; Frank Porreca
Journal:  Neurosci Lett       Date:  2013-08-19       Impact factor: 3.046

5.  Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry.

Authors:  Edita Navratilova; Jennifer Y Xie; Alec Okun; Chaoling Qu; Nathan Eyde; Shuang Ci; Michael H Ossipov; Tamara King; Howard L Fields; Frank Porreca
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

6.  Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.

Authors:  Jennifer Y Xie; Lindsey A Chew; Xiaofang Yang; Yuying Wang; Chaoling Qu; Yue Wang; Lauren M Federici; Stephanie D Fitz; Matthew S Ripsch; Michael R Due; Aubin Moutal; May Khanna; Fletcher A White; Todd W Vanderah; Philip L Johnson; Frank Porreca; Rajesh Khanna
Journal:  Pain       Date:  2016-09       Impact factor: 7.926

7.  Selective modulation of tonic aversive qualities of neuropathic pain by morphine in the central nucleus of the amygdala requires endogenous opioid signaling in the anterior cingulate cortex.

Authors:  Edita Navratilova; Kelsey Nation; Bethany Remeniuk; Volker Neugebauer; Kirsty Bannister; Anthony H Dickenson; Frank Porreca
Journal:  Pain       Date:  2020-03       Impact factor: 7.926

8.  Multiple sites and actions of gabapentin-induced relief of ongoing experimental neuropathic pain.

Authors:  Kirsty Bannister; Chaoling Qu; Edita Navratilova; Janice Oyarzo; Jennifer Yanhua Xie; Tamara King; Anthony H Dickenson; Frank Porreca
Journal:  Pain       Date:  2017-12       Impact factor: 7.926

9.  Positive allosteric modulators of nonbenzodiazepine γ-aminobutyric acidA receptor subtypes for the treatment of chronic pain.

Authors:  Timothy B C Johnstone; Jennifer Y Xie; Chaoling Qu; David J Wasiak; Derk J Hogenkamp; Frank Porreca; Kelvin W Gee
Journal:  Pain       Date:  2019-01       Impact factor: 7.926

10.  Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients.

Authors:  Takeshi Fukushima; Hideaki Iizuka; Ayaka Yokota; Takehiro Suzuki; Chihiro Ohno; Yumiko Kono; Minami Nishikiori; Ayaka Seki; Hideaki Ichiba; Yoshinori Watanabe; Seiji Hongo; Mamoru Utsunomiya; Masaki Nakatani; Kiyomi Sadamoto; Takashi Yoshio
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.